
Multiple arterial phases to evaluate Hepato Cellular Carcinoma (HCC) acquired with TWIST-VIBE
Image courtesy of University Hospital Grosshadern, Munich, Germany
MRI plays an important role for the assessment of liver cancer
Research on the liver cancer statistics done by World Cancer Research Fund International shows that Thailand and Vietnam are among the top 10 countries with the highest incidence rate of liver cancer, whereas Singapore and Philippines are among the top 252. The incidence rate in South-East Asia is expected to grow by 14.6% until 20251.
Staging of oncological patients can be challenging as it affects treatment decisions. This is why, magnetic resonance (MR) imaging plays an important role in the evaluation of a wide range of benign and malignant focal hepatic lesions3. MR imaging is recommended by guidelines of the American College of Radiology as the imaging test of choice for abdominal examinations4.
However, for an accurate diagnosis of hepatic lesions and their staging, precise contrast timing is critical.